These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 11121455)

  • 21. A review of autologous hematopoietic cell transplantation.
    Blume KG; Thomas ED
    Biol Blood Marrow Transplant; 2000; 6(1):1-12. PubMed ID: 10707994
    [No Abstract]   [Full Text] [Related]  

  • 22. The use of hematopoietic growth factors for high-dose chemotherapy and peripheral blood progenitor cell transplantation.
    Kanz L; Brugger W; Mertelsmann R
    Semin Oncol; 1994 Dec; 21(6 Suppl 16):10-8. PubMed ID: 7528446
    [No Abstract]   [Full Text] [Related]  

  • 23. [High-dose therapy with autologous stem cell support in malignant diseases].
    Wisløff F; Brinch L; Bruserud O; Dahl IM; Lamvik J
    Tidsskr Nor Laegeforen; 1994 Oct; 114(26):3115. PubMed ID: 7974434
    [No Abstract]   [Full Text] [Related]  

  • 24. Peripheral blood progenitor cell transplantation: economic issues.
    Yee GC
    Pharmacotherapy; 1998; 18(1 Pt 2):9S-16S. PubMed ID: 9473174
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Perioperative management after high-dose chemotherapy with autologous or allogeneic hematopoietic stem cell transplantation for pediatric solid tumors.
    Uehara S; Oue T; Nakahata K; Nara K; Ueno T; Owari M; Usui N; Miyamura T; Hashii Y
    Eur J Pediatr Surg; 2015 Feb; 25(1):118-22. PubMed ID: 25111275
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [High dose chemotherapy with autologous stem cell support in cancer patients].
    Abrahamsen JF; Kristoffersen EK; Hervig T; Ekanger R; Nesthus I; Ulvestad E
    Tidsskr Nor Laegeforen; 2000 May; 120(13):1523-8. PubMed ID: 10916472
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A population-based cohort study of late mortality in adult autologous hematopoietic stem cell transplant recipients in Australia.
    Ashton LJ; Le Marsney RE; Dodds AJ; Nivison-Smith I; Wilcox L; O'Brien TA; Vajdic CM
    Biol Blood Marrow Transplant; 2014 Jul; 20(7):937-45. PubMed ID: 24631736
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-dose chemotherapy with autologous hematopoietic stem-cell support for breast cancer in North America.
    Crump M; Gluck S; Pritchard K; Shepherd L; Pater J
    J Clin Oncol; 1998 Feb; 16(2):800-2. PubMed ID: 9469374
    [No Abstract]   [Full Text] [Related]  

  • 29. Autologous hematopoietic stem cell transplantation-what determines the outcome: an experience from North India.
    Kumar L; Malik PS; Prakash G; Prabu R; Radhakrishnan V; Katyal S; Hariprasad R
    Ann Hematol; 2011 Nov; 90(11):1317-28. PubMed ID: 21409382
    [TBL] [Abstract][Full Text] [Related]  

  • 30. P. carinii pneumonia (PCP) following tandem cycles of high-dose chemotherapy and autologous PBPC support.
    Meisenberg B; McKee D
    Bone Marrow Transplant; 1996 Oct; 18(4):823. PubMed ID: 8899206
    [No Abstract]   [Full Text] [Related]  

  • 31. [High dose therapy and stem cell transplantation. A new path in tumor therapy].
    Kanz L
    Internist (Berl); 1997 Nov; 38(11):1045-9. PubMed ID: 9453952
    [No Abstract]   [Full Text] [Related]  

  • 32. CD34 may be used to determine the adequacy of a stem cell harvest for hematologic recovery following high dose chemotherapy.
    Zimmerman TM; Lee WJ; Bender JG; Mick R; Williams SF
    Prog Clin Biol Res; 1994; 389():303-8. PubMed ID: 7535435
    [No Abstract]   [Full Text] [Related]  

  • 33. The microbiome in hematopoietic stem cell transplant recipients and cancer patients: Opportunities for clinical advances that reduce infection.
    Koh AY
    PLoS Pathog; 2017 Jun; 13(6):e1006342. PubMed ID: 28662165
    [No Abstract]   [Full Text] [Related]  

  • 34. Delayed chemotherapy-induced nausea and vomiting in autologous hematopoietic cell transplant patients: an exploratory analysis.
    Gonella S; Di Giulio P
    Tumori; 2015 Nov; 101(6):e154-9. PubMed ID: 26045114
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A retrospective comparison of three different methods for mobilization of peripheral blood stem cells.
    Mangan KF; Mullaney MT; Klumpp TR; Goldberg SL; Macdonald JS
    Prog Clin Biol Res; 1994; 389():441-8. PubMed ID: 7535452
    [No Abstract]   [Full Text] [Related]  

  • 36. [The use of peripheral blood progenitor cells as an autologous hematopoietic support in high-dose chemotherapy. II. The experience of the Hematological Intensive Care Unit of the IPOFG. Franciso Gentil Portuguese Institute of Oncology].
    Silva MR; Passos-Coelho JL; da Costa FL; Machado MA; Miranda N; Miranda MH; Parreira A
    Acta Med Port; 1999; 12(7-11):275-81. PubMed ID: 10707465
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Re-examining the role of high-dose chemotherapy in the treatment of light chain amyloidosis.
    Devine SM
    Biol Blood Marrow Transplant; 2014 Jan; 20(1):14-9. PubMed ID: 24291621
    [No Abstract]   [Full Text] [Related]  

  • 38. Current Use and Trends in Hematopoietic Cell Transplantation in the United States.
    D'Souza A; Lee S; Zhu X; Pasquini M
    Biol Blood Marrow Transplant; 2017 Sep; 23(9):1417-1421. PubMed ID: 28606646
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Life-threatening carboplatin hypersensitivity during conditioning for autologous PBSC transplantation: successful rechallenge after desensitization.
    Kook H; Kim KM; Choi SH; Choi BS; Kim HJ; Chung SY; Choi SJ; Hwang TJ
    Bone Marrow Transplant; 1998 Apr; 21(7):727-9. PubMed ID: 9578315
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is high-dose chemotherapy with autologous hematopoietic stem cell transplantation in breast cancer patients a done deal?
    Cheng YC; Ueno NT
    Womens Health (Lond); 2010 Jul; 6(4):481-5. PubMed ID: 20597609
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.